Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

Antimicrobial Agents and Chemotherapy
Michael P MalakhovFang Fang

Abstract

Influenza is a highly infectious disease characterized by recurrent annual epidemics and unpredictable major worldwide pandemics. Rapid spread of the highly pathogenic avian H5N1 strain and escalating human infections by the virus have set off the alarm for a global pandemic. To provide an urgently needed alternative treatment modality for influenza, we have generated a recombinant fusion protein composed of a sialidase catalytic domain derived from Actinomyces viscosus fused with a cell surface-anchoring sequence. The sialidase fusion protein is to be applied topically as an inhalant to remove the influenza viral receptors, sialic acids, from the airway epithelium. We demonstrate that a sialidase fusion construct, DAS181, effectively cleaves sialic acid receptors used by both human and avian influenza viruses. The treatment provides long-lasting effect and is nontoxic to the cells. DAS181 demonstrated potent antiviral and cell protective efficacies against a panel of laboratory strains and clinical isolates of IFV A and IFV B, with virus replication inhibition 50% effective concentrations in the range of 0.04 to 0.9 nM. Mouse and ferret studies confirmed significant in vivo efficacy of the sialidase fusion in both prophylactic...Continue Reading

References

Jun 12, 1975·Biochimica Et Biophysica Acta·F A MeyerR A Gelman
Apr 1, 1992·The American Review of Respiratory Disease·P H JarreauI Macquin-Mavier
Apr 1, 1992·Current Opinion in Cell Biology·A Varki
Sep 22, 1992·European Journal of Pharmacology·H KaiT Miyata
Jul 1, 1990·Infection and Immunity·N BakerC Svanborg-Edén
Apr 1, 1989·Infection and Immunity·H MarcusN R Baker
May 1, 1989·Biological Chemistry Hoppe-Seyler·M TeufelR Schauer
Apr 1, 1989·Journal of Virological Methods·P D ReumanG M Schiff
Oct 1, 1986·Antiviral Research·R W SidwellR K Robins
Jan 1, 1988·Reviews of Infectious Diseases·H Smith, C Sweet
Apr 1, 1985·European Journal of Clinical Microbiology·R Ramphal, M Pyle
May 1, 1973·The Histochemical Journal·R Drzeniek
Mar 1, 1984·Reviews of Infectious Diseases·V L Sutter
Jan 1, 1982·Advances in Carbohydrate Chemistry and Biochemistry·R Schauer
Nov 15, 1982·European Journal of Biochemistry·L D BergelsonE V Fomina-Ageeva
Mar 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Varki
Nov 24, 1999·Glycobiology·E MontiG Borsani
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M K PangburnA K Sharma
Jul 27, 2000·Glycobiology·S J StrayG M Air
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·D F SmeeR W Sidwell
May 5, 2001·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·K E Achyuthan, A M Achyuthan
Mar 28, 2003·The Journal of Infectious Diseases·Jonathan A McCullers, Kimberly C Bartmess
Apr 15, 2003·Clinical Microbiology Reviews·Kelly J Henrickson
Jan 20, 2004·The Pediatric Infectious Disease Journal·Ville T Peltola, Jonathan A McCullers
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mikhail N MatrosovichHans-Dieter Klenk
Jul 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·H ChenK Yu

❮ Previous
Next ❯

Citations

Dec 2, 2006·Nature Reviews. Drug Discovery·Erik De Clercq
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Debra M Eckert, Michael S Kay
Feb 19, 2011·The Journal of Biological Chemistry·Shen ShenAravind Asokan
Nov 17, 2007·The Journal of Infectious Diseases·Jessica A BelserJacqueline M Katz
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Arnold S Monto, Richard J Whitley
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick Hayden
Feb 23, 2010·The Journal of Infectious Diseases·Maria HedlundFang Fang
Oct 10, 2012·The Journal of Infectious Diseases·Ronald B MossRoy T Steigbigel
Oct 10, 2012·The Journal of Infectious Diseases·Michael G Ison
Apr 25, 2008·The Journal of Antimicrobial Chemotherapy·John M NichollsFang Fang
Nov 7, 2009·The Journal of Antimicrobial Chemotherapy·Shin-Ru ShihJohn T-A Hsu
Apr 9, 2010·The Journal of Antimicrobial Chemotherapy·Ronald B MossFang Fang
Nov 26, 2010·The Journal of Antimicrobial Chemotherapy·Gallen B Triana-BaltzerFang Fang
May 17, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jeffrey L LarsonFang Fang
Jul 15, 2009·Antimicrobial Agents and Chemotherapy·Renee W Y ChanJohn M Nicholls
Feb 24, 2009·Antimicrobial Agents and Chemotherapy·Hong Zhang
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Elena A GovorkovaRobert G Webster
Oct 18, 2007·Annual Review of Medicine·Anne Moscona
Dec 17, 2009·Blood·Corey CasperMichael Boeckh
Aug 31, 2010·Paediatric Drugs·Steven M Smith, John G Gums
Jul 10, 2010·Drugs·David A BoltzElena A Govorkova
Dec 22, 2009·Future Microbiology·Benjamin G HaleAdolfo García-Sastre
Jun 4, 2014·BMC Infectious Diseases·Roberto GaspariniDonatella Panatto
Sep 2, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yi-Bin ChenFrancisco M Marty
Apr 16, 2014·Proceedings of the National Academy of Sciences of the United States of America·Helen ConnarisGarry L Taylor
Apr 5, 2014·Cellular and Molecular Life Sciences : CMLS·Arianna LoregianGiorgio Palù
Nov 29, 2014·BMC Infectious Diseases·Theodoros KelesidisSotirios Tsiodras
Oct 30, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roy F ChemalyMichael J Boeckh
Sep 13, 2014·The Lancet Infectious Diseases·Jake DunningUNKNOWN International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)
Mar 29, 2011·Expert Opinion on Pharmacotherapy·Paolo Preziosi
Jan 18, 2011·Expert Opinion on Investigational Drugs·Aarthi NarayananKylene Kehn-Hall
Oct 14, 2014·Expert Opinion on Investigational Drugs·Manjit K SidhuAdam T Hill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.